Int J Med Sci 2019; 16(4):507-512. doi:10.7150/ijms.30759 This issue Cite

Review

Engineering of Human Corneal Endothelial Cells In Vitro

Qin Zhu1, Yingting Zhu2✉, Sean Tighe2, Yongsong Liu3, Min Hu1✉

1. Department of Ophthalmology, The Second People's Hospital of Yunnan Province (Fourth Affiliated Hospital of Kunming Medical University); Yunnan Eye Institute; Key Laboratory of Yunnan Province for the Prevention and Treatment of ophthalmology (2017DG008); Provincial Innovation Team for Cataract and Ocular Fundus Disease (2017HC010); Expert Workstation of Yao Ke (2017IC064), Kunming, 650021 China
2. Tissue Tech, Inc., Ocular Surface Center, and Ocular Surface Research & Education Foundation, Miami, FL, 33173 USA
3. Department of Ophthalmology, Yan' An Hospital of Kunming City, Kunming, 650051, China

Citation:
Zhu Q, Zhu Y, Tighe S, Liu Y, Hu M. Engineering of Human Corneal Endothelial Cells In Vitro. Int J Med Sci 2019; 16(4):507-512. doi:10.7150/ijms.30759. https://www.medsci.org/v16p0507.htm
Other styles

File import instruction

Abstract

Human corneal endothelial cells are responsible for controlling corneal transparency, however they are notorious for their limited proliferative capability. Thus, damage to these cells may cause irreversible blindness. Currently, the only way to cure blindness caused by corneal endothelial dysfunction is via corneal transplantation of a cadaver donor cornea with healthy corneal endothelium. Due to severe shortage of donor corneas worldwide, it has become paramount to develop human corneal endothelial grafts in vitro that can subsequently be transplanted in humans. Recently, we have reported effective expansion of human corneal endothelial cells by reprogramming the cells into progenitor status through use of p120-Kaiso siRNA knockdown. This new reprogramming approach circumvents the need of using induced pluripotent stem cells or embryonic stem cells. Successful promotion of this technology will encourage scientists to re-think how "contact inhibition" can safely be perturbed to our benefit, i.e., effective engineering of an in vivo-like tissue while successful maintaining the normal phenotype. In this review, we present current advances in reprogramming corneal endothelial cells in vitro, detail the methods to successful engineer human corneal endothelial grafts, and discuss their future clinical applications to cure corneal blindness.

Keywords: cornea, endothelium, progenitor, engineering


Citation styles

APA
Zhu, Q., Zhu, Y., Tighe, S., Liu, Y., Hu, M. (2019). Engineering of Human Corneal Endothelial Cells In Vitro. International Journal of Medical Sciences, 16(4), 507-512. https://doi.org/10.7150/ijms.30759.

ACS
Zhu, Q.; Zhu, Y.; Tighe, S.; Liu, Y.; Hu, M. Engineering of Human Corneal Endothelial Cells In Vitro. Int. J. Med. Sci. 2019, 16 (4), 507-512. DOI: 10.7150/ijms.30759.

NLM
Zhu Q, Zhu Y, Tighe S, Liu Y, Hu M. Engineering of Human Corneal Endothelial Cells In Vitro. Int J Med Sci 2019; 16(4):507-512. doi:10.7150/ijms.30759. https://www.medsci.org/v16p0507.htm

CSE
Zhu Q, Zhu Y, Tighe S, Liu Y, Hu M. 2019. Engineering of Human Corneal Endothelial Cells In Vitro. Int J Med Sci. 16(4):507-512.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image